Cardiovascular effects and clearance of arginine vasopressin in the fetal lamb

S. Wiriyathian, J. C. Porter, R. P. Naden, C. R. Rosenfeld

Research output: Contribution to journalArticle

Abstract

Increased fetal secretion of arginine vasopressin (AVP) occurs in association with complicated pregnancies, asphyxia, and meconium-stained amniotic fluid (AF); yet, the role of AVP in fetal homeostasis remains unclear. Using chronically instrumented, near-term lamb fetuses (n = 8), we have ascertained the cardiovascular responses to doses of AVP ranging from 1.94 to 8.73 mU/min, the clearance of AVP from plasma, and the occurrence of meconium release into AF during AVP infusions. AVP administration resulted in a dose-related rise in arterial pressure; although heart rate fell, the decline was not dose-related and occurred before the pressor response. Clearance of plasma AVP was 60 ± 8.7 ml · kg-1 · min-1, and the half-time in plasma was 2.8 min. AVP was not cleared across the fetal placenta nor by fetal-maternal transport. However, the AF concentration of AVP rose fourfold after the infusion of AVP was stopped. Meconium release into AF occurred in fetuses infused with AVP at rates ≥7.76 mU/min. AVP has hemodynamic effects that mimic fetal responses to intrauterine 'stress' and may be causally associated with the fetal release of meconium into AF. Furthermore, plasma AVP is cleared in part by the fetal kidney.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume8
Issue number1
StatePublished - 1983

Fingerprint

Arginine Vasopressin
Amniotic Fluid
Meconium
Fluids
Plasmas
Fetus
Asphyxia
Hemodynamics
Placenta
Arterial Pressure
Homeostasis
Heart Rate

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology

Cite this

Cardiovascular effects and clearance of arginine vasopressin in the fetal lamb. / Wiriyathian, S.; Porter, J. C.; Naden, R. P.; Rosenfeld, C. R.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 8, No. 1, 1983.

Research output: Contribution to journalArticle

Wiriyathian, S. ; Porter, J. C. ; Naden, R. P. ; Rosenfeld, C. R. / Cardiovascular effects and clearance of arginine vasopressin in the fetal lamb. In: American Journal of Physiology - Endocrinology and Metabolism. 1983 ; Vol. 8, No. 1.
@article{1e553cc472a8443d82e63e331613f4bb,
title = "Cardiovascular effects and clearance of arginine vasopressin in the fetal lamb",
abstract = "Increased fetal secretion of arginine vasopressin (AVP) occurs in association with complicated pregnancies, asphyxia, and meconium-stained amniotic fluid (AF); yet, the role of AVP in fetal homeostasis remains unclear. Using chronically instrumented, near-term lamb fetuses (n = 8), we have ascertained the cardiovascular responses to doses of AVP ranging from 1.94 to 8.73 mU/min, the clearance of AVP from plasma, and the occurrence of meconium release into AF during AVP infusions. AVP administration resulted in a dose-related rise in arterial pressure; although heart rate fell, the decline was not dose-related and occurred before the pressor response. Clearance of plasma AVP was 60 ± 8.7 ml · kg-1 · min-1, and the half-time in plasma was 2.8 min. AVP was not cleared across the fetal placenta nor by fetal-maternal transport. However, the AF concentration of AVP rose fourfold after the infusion of AVP was stopped. Meconium release into AF occurred in fetuses infused with AVP at rates ≥7.76 mU/min. AVP has hemodynamic effects that mimic fetal responses to intrauterine 'stress' and may be causally associated with the fetal release of meconium into AF. Furthermore, plasma AVP is cleared in part by the fetal kidney.",
author = "S. Wiriyathian and Porter, {J. C.} and Naden, {R. P.} and Rosenfeld, {C. R.}",
year = "1983",
language = "English (US)",
volume = "8",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Cardiovascular effects and clearance of arginine vasopressin in the fetal lamb

AU - Wiriyathian, S.

AU - Porter, J. C.

AU - Naden, R. P.

AU - Rosenfeld, C. R.

PY - 1983

Y1 - 1983

N2 - Increased fetal secretion of arginine vasopressin (AVP) occurs in association with complicated pregnancies, asphyxia, and meconium-stained amniotic fluid (AF); yet, the role of AVP in fetal homeostasis remains unclear. Using chronically instrumented, near-term lamb fetuses (n = 8), we have ascertained the cardiovascular responses to doses of AVP ranging from 1.94 to 8.73 mU/min, the clearance of AVP from plasma, and the occurrence of meconium release into AF during AVP infusions. AVP administration resulted in a dose-related rise in arterial pressure; although heart rate fell, the decline was not dose-related and occurred before the pressor response. Clearance of plasma AVP was 60 ± 8.7 ml · kg-1 · min-1, and the half-time in plasma was 2.8 min. AVP was not cleared across the fetal placenta nor by fetal-maternal transport. However, the AF concentration of AVP rose fourfold after the infusion of AVP was stopped. Meconium release into AF occurred in fetuses infused with AVP at rates ≥7.76 mU/min. AVP has hemodynamic effects that mimic fetal responses to intrauterine 'stress' and may be causally associated with the fetal release of meconium into AF. Furthermore, plasma AVP is cleared in part by the fetal kidney.

AB - Increased fetal secretion of arginine vasopressin (AVP) occurs in association with complicated pregnancies, asphyxia, and meconium-stained amniotic fluid (AF); yet, the role of AVP in fetal homeostasis remains unclear. Using chronically instrumented, near-term lamb fetuses (n = 8), we have ascertained the cardiovascular responses to doses of AVP ranging from 1.94 to 8.73 mU/min, the clearance of AVP from plasma, and the occurrence of meconium release into AF during AVP infusions. AVP administration resulted in a dose-related rise in arterial pressure; although heart rate fell, the decline was not dose-related and occurred before the pressor response. Clearance of plasma AVP was 60 ± 8.7 ml · kg-1 · min-1, and the half-time in plasma was 2.8 min. AVP was not cleared across the fetal placenta nor by fetal-maternal transport. However, the AF concentration of AVP rose fourfold after the infusion of AVP was stopped. Meconium release into AF occurred in fetuses infused with AVP at rates ≥7.76 mU/min. AVP has hemodynamic effects that mimic fetal responses to intrauterine 'stress' and may be causally associated with the fetal release of meconium into AF. Furthermore, plasma AVP is cleared in part by the fetal kidney.

UR - http://www.scopus.com/inward/record.url?scp=0021079501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021079501&partnerID=8YFLogxK

M3 - Article

VL - 8

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1

ER -